Literature DB >> 17623716

On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation.

Jochen Wilpert1, Marcel Geyer, Przemyslaw Pisarski, Oliver Drognitz, Christian Schulz-Huotari, Anette Gropp, Heike Goebel, Peter Gerke, Sven Teschner, Gerd Walz, Johannes Donauer.   

Abstract

BACKGROUND: Since 2001, approximately 100 ABO-incompatible kidney transplantations have been performed in Europe. The standard protocol, employed by most transplant centres, uses rituximab and scheduled pre-emptive antigen-specific immunoadsorption on post-operative days 3, 6 and 9.
METHODS: Our centre has performed 22 ABO-incompatible kidney transplantations since 2004, using a different approach; like in Sweden, all patients received immunoadsorptions preoperatively, but instead of scheduling pre-emptive post-transplant immunoadsorptions, we submitted patients to immunoadsorptions post-operatively only, if their isoagglutinine titers (IgG-Anti-A or -B) exceeded certain thresholds. These thresholds were greater than 1 : 8 in the first post-operative week and greater than 1 : 16 in the second post-operative week, respectively.
RESULTS: A shorter pre-operative length on dialysis, a blood-type constellation of donor A1/recipient 0 and 9a high initial starting-titer were identified as predictors for post-operative immunoadsorptions.
CONCLUSION: Using this on-demand strategy, our data reveal that a titer-dependent protocol reduces costs at no additional risk for the patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17623716     DOI: 10.1093/ndt/gfm460

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Vienna experience of ABO-incompatible living-donor kidney transplantation.

Authors:  Michael Haidinger; Sabine Schmaldienst; Günther Körmöczi; Heinz Regele; Afschin Soleiman; Dieter Schwartz; Kurt Derfler; Rudolf Steininger; Ferdinand Mühlbacher; Georg A Böhmig
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy.

Authors:  Maria Sassi; Umberto Maggiore; Carlo Buzio; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

3.  Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts.

Authors:  Jeong Kye Hwang; Sang Il Kim; Bum Soon Choi; Cheol Woo Yang; Yong Soo Kim; In Sung Moon; Ji Il Kim
Journal:  J Korean Surg Soc       Date:  2011-07-11

Review 4.  Maximising living donation with paediatric blood-group-incompatible renal transplantation.

Authors:  Nizam Mamode; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2012-09-02       Impact factor: 3.714

Review 5.  Therapeutic apheresis in kidney transplantation: An updated review.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  World J Transplant       Date:  2019-10-28

6.  The First North American Experience Using Glycosorb Immunoadsorption Columns for Blood Group-Incompatible Kidney Transplantation.

Authors:  Katerina Pavenski; Megan Bucholz; Patti Lou Cheatley; Elizabeth Krok; Monique Anderson; Gv Ramesh Prasad; Mohammed Azfar Qureshi; Galo Meliton; Jeffrey Zaltzman
Journal:  Can J Kidney Health Dis       Date:  2020-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.